Literature DB >> 31357135

Stress, mood, and cortisol during daily life in women with Premenstrual Dysphoric Disorder (PMDD).

Theresa Beddig1, Iris Reinhard2, Christine Kuehner3.   

Abstract

Premenstrual Dysphoric Disorder (PMDD) is characterized by significant emotional, physical and behavioral distress during the late luteal phase that remits after menses onset. Outlined as a new diagnostic category in DSM-5, the mechanisms underlying PMDD are still insufficiently known. Previous research suggests that PMDD exacerbates with stressful events, indicating a dysregulation of the hypothalamic-pituitary-adrenal axis. However, studies measuring stress-related processes in affected women in real-time and real-life are lacking. We conducted an Ambulatory Assessment (AA) study to compare subjective stress reactivity together with basal and stress-reactive cortisol activity across the menstrual cycle in women with and without PMDD. Women with current PMDD (n = 61) and age- and education matched controls (n = 61) reported momentary mood, rumination, and daily events via smartphones at semi-random time points 8 times a day over two consecutive days per cycle phase (menstrual, follicular, ovulatory, and late luteal). Twenty minutes after assessments participants collected saliva cortisol samples. Three additional morning samples determined the cortisol awakening response (CAR). Women with PMDD reported particular high daily life stress and high arousal negative affect (NAhigh) towards stressors during the late luteal phase. High momentary stress levels were linked to lower levels of high arousal positive affect (PAhigh) and to higher levels of rumination in PMDD women compared to controls irrespective of cycle phase. Across groups, more stress was linked to higher levels of low arousal NA (NAlow) and to lower levels of low arousal PA (PAlow). Moreover, PMDD was associated with a delayed CAR peak and a flattened diurnal cortisol slope. While neither group showed cortisol reactivity towards daily life stress directly, high momentary NAhigh and low momentary PA predicted high levels of cortisol across groups, whereas high momentary rumination predicted high cortisol output only in healthy women. In this AA-study we identified important stress-related psychological and endocrinological within-person variability in women with PMDD during daily life. Further research is warranted targeting identified AA-based mechanisms to study their predictive role for the clinical course of PMDD and to provide evidence-based therapeutic options for affected women.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ambulatory assessment; Cortisol; Daily life stress; Hypothalamic pituitary adrenal (HPA) axis; Multilevel modeling; Premenstrual dysphoric disorder

Mesh:

Substances:

Year:  2019        PMID: 31357135     DOI: 10.1016/j.psyneuen.2019.104372

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  5 in total

Review 1.  Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome.

Authors:  Lara Tiranini; Rossella E Nappi
Journal:  Fac Rev       Date:  2022-04-28

Review 2.  Premenstrual Exacerbations of Mood Disorders: Findings and Knowledge Gaps.

Authors:  Christine Kuehner; Sibel Nayman
Journal:  Curr Psychiatry Rep       Date:  2021-10-09       Impact factor: 5.285

3.  Anxiety-like Behavior and GABAAR/BDZ Binding Site Response to Progesterone Withdrawal in a Stress-Vulnerable Strain, the Wistar Kyoto Rats.

Authors:  Dannia Islas-Preciado; Gabriela Ugalde-Fuentes; Isabel Sollozo-Dupont; María Eva González Trujano; Nancy Cervantes-Anaya; Erika Estrada-Camarena; Carolina López-Rubalcava
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

4.  Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle.

Authors:  Liisa Hantsoo; C Neill Epperson
Journal:  Neurobiol Stress       Date:  2020-02-04

5.  Study on urinary metabolomics of premenstrual dysphoric disorder patients with liver-qi depression syndrome treated with Xiaoyaosan: Study Protocol Clinical Trial (SPIRIT Compliant).

Authors:  Mengbai Xu; Yanfeng Liu; Yu Guo; Chenyue Liu; Yueyun Liu; Zhiyi Yan; Yajing Hou; Xiaojuan Li; Qingyu Ma; Xuan Zhou; Liuqing Liu; Sheng Huang; Jiaxu Chen
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.